+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Association between sonographic diagnosis of fatty liver with histopathologic abnormalities and liver biopsy findings in middle age patient with non-alcoholic fatty liver disease



Association between sonographic diagnosis of fatty liver with histopathologic abnormalities and liver biopsy findings in middle age patient with non-alcoholic fatty liver disease



Advanced Biomedical Research 5: 122



Liver biopsy is required to diagnose non-alcoholic steatohepatitis in patients with suspected non-alcoholic fatty liver disease (NAFLD). This study aimed to examine the relationship between sonographic diagnosis of fatty liver with histopathologic abnormalities and liver biopsy findings in patient with NAFLD. In this cross-sectional study, a total of 180 patients, with an age range of 18-60 year old, with NAFLD based on ultrasonograghic findings were evaluated. Age, sex, body mass index, diabetes mellitus, hypertension, family history of liver disease and laboratory parameters recorded for all patients. Hence, grade of steatosis and stage of fibrosis were evaluated by liver biopsy. A total of 220 patients were enrolled. Liver biopsy was performed in 180 patients. Mean age was 43 ± 10.6 years old and 66% were male. Ultrasonograghic findings showed mild, moderate and severe NAFLD was define in 100 (55.5%), 72 (40%) and 8 (4.5%) of patients, respectively. Liver biopsies showed that steatosis scores of <5%, 5-33% and 33-66% was define in 56 (31%), 116 (64%) and 9 (5%) of patients, respectively. Furthermore, fibrosis was defined as follow; none 92 (51%), mild 68 (38%), moderate 11 (6%), bridging 5 (3%) and cirrhosis 3 (2%) patients. There was no statistically significant relationship between ultrasonograghic findings and steatosis scores (P = 0.44), but statistically significant relationship was found between ultrasonograghic findings and fibrosis stage (P = 0.017). Findings revealed that, in patients with NAFLD, ultrasonographic finding were not in associate to steatosis, but were in relation with fibrosis stage.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 057251539

Download citation: RISBibTeXText

PMID: 27563632


Related references

Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients. Advanced Biomedical Research 5: 40, 2016

Sat-300-Prospective liver biopsy-based prevalence of non-alcoholic fatty liver disease and steatohepatitis among a large middle-aged population utilizing FibroScan, LiverMultiscan and magnetic resonance elastography to guide liver biopsy. Journal of Hepatology 70(1): e770-e771, 2019

Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential. Liver International 38: 64-66, 2018

Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential. Liver International 38(Suppl. 1): 64-66, 2018

Su1372 Eus Guided Liver Biopsy Is More Cost-Effective Than Percutaneous Liver Biopsy In Patients With Non-Alcoholic Fatty Liver Disease(Nafld). Gastrointestinal Endoscopy 87(6): Ab326-Ab327, 2018

Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review. Obesity Reviews 17(1): 68-80, 2016

Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease. Biomedical Reports 5(2): 188-192, 2016

Liver biopsy versus noninvasive methods--fibroscan and fibrotest in the diagnosis of non-alcoholic fatty liver disease: a review of the literature. Romanian Journal of Internal Medicine 47(4): 331-340, 2011

Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease. Clinics in Liver Disease 11(1): 25-35, Viii, 2007

Su1538 - The Relationship Between Serum Autotaxin Levels and Liver Histological Findings in Patient with Non-Alcoholic Fatty Liver Disease. Gastroenterology 154(6): S-1171, 2018

Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease. Hepatology International 12(1): 44-55, 2018

Transient elastography and serum biomarkers: two-step screening methods for liver fibrosis in non-alcoholic fatty liver disease before liver biopsy. Expert Opinion on Medical Diagnostics 6(5): 377-380, 2013

Assessment of Fatty Liver Index (Fli) for the Diagnosis of Non-Alcoholic Fatty Liver Disease (Nafld) in Morbidly Obese Patients. Gastroenterology 144(5): S-125, 2013

Mo1015 Liver Function Breath Tests for Differentiation of Steatohepatitis From Simple Fatty Liver in Patients With Non-Alcoholic Fatty Liver Disease. Gastroenterology 144(5): S-1013, 2013

P273 The Pathological Progression Of Non-Alcoholic Fatty Liver Disease Correlates With Gut Microbiota Composition In Mice: From Non-Alcoholic Fatty Liver To Non-Alcoholic Steatohepatitis. Journal of Hepatology 60(1): S155-S157, 2014